GLOBAL BLOOD THERAPE

GBT
Delayed Quote. Delayed  - 02/26 04:00:00 pm
42.6USD -2.07%
Upcoming events on GLOBAL BLOOD THERAPEUTICS, INC.
02/26/21 | 02:20pm SVB Leerink Global Healthcare Conference
03/01/21 | 11:40am Cowen Health Care Conference
03/01/21 | 02:40pm Non-Malignant Hematology Conference - Panel
05/12/21 Q1 2021 Earnings Release (Projected)

Past events on GLOBAL BLOOD THERAPEUTICS, INC.
02/24/21 | 04:30pmFY 2020 Earnings Call
02/24/21FY 2020 Earnings Release
01/12/21 | 11:40amJP Morgan Healthcare Conference
12/07/20Analyst & Investor Day

Upcoming sector events for GLOBAL BLOOD THERAPEUTICS, INC.
02/26/21 | 04:35pm REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 010
02/26/21 REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 290
02/26/21 REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 447
02/26/21 REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 425

Past sector events for GLOBAL BLOOD THERAPEUTICS, INC.
02/25/21 | 01:40pmGILEAD SCIENCES, INC. : SVB Leerink Global Healthcare Conference
02/25/21 | 01:40pmEXACT SCIENCES CORPORATION : SVB Leerink Global Healthcare Conference
02/25/21IOVANCE BIOTHERAPEUTICS, INC. : FY 2020 Earnings Release
02/25/21VIR BIOTECHNOLOGY, INC. : FY 2020 Earnings Release

Annual results
Previous yearNext Year
Annual results20202021 (e)
Sales
M $
Released
Forecast
Spread
124
121
1,9%

211
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-236
-233
-1,1%

-235
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-244
-245
0,27%

-241
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-248
-245
-0,95%

-242
Net income
M $
Released
Forecast
Spread
-248
-245
-0,91%

-244
EPS
$
Released
Forecast
Spread
-4,04
-3,99
-1,3%

-3,74
Announcement Date02/24/2021


Quarterly / Semiannualy publications
Previous periodNext period
Quarterly results2020 Q42021 Q1 (e)
Sales
M $
Released
Forecast
Spread
41,3
39,1
5,7%

43,4
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-59,0
-57,9
-1,9%

-64,9
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-60,4
-61,2
1,3%

-62,1
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-61,8
-60,3
-2,5%

-62,1
Net income
M $
Released
Forecast
Spread
-61,8
-60,0
-3,0%

-63,6
EPS
$
Released
Forecast
Spread
-1,00
-0,96
-4,7%

-1,00
Announcement Date02/24/2021

Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise